A Phase 2a, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea predominant Irritable Bowel Syndrome (IBS-D)

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

2

Condition

N/A

Treatment

N/A

Clinical Study ID

TX228459
  • Ages 18-65
  • All Genders

Study Summary

Are you or a loved one suffering from the abdominal (belly) pain and discomfort, abnormal bowel habits, and bloating of Irritable Bowel Syndrome with Diarrhea (IBS-D)?

Right now, clinical research doctors are seeking volunteers for an investigational drug study in your area to learn how it affects people with IBS-D. Qualified study volunteers may receive the following at no cost:

• Investigational drug for Irritable Bowel Syndrome with Diarrhea

• Study-related care from a local doctor

• Compensation for time and travel

To qualify, you must be 18 to 65 years of age, living with IBS-D for at least 6 months, and have no history of inflammatory or immune-mediated GI disorders including, but not limited to, inflammatory bowel disease (Crohn's disease, ulcerative colitis, microscopic colitis, and celiac disease). Study doctors will help determine if this study is right for you.

Eligibility Criteria

Inclusion

Inclusion:

Living with IBS-D for at least 6 months

Ages 18-65 inclusive

Both Male and Female

Exclusion:

No IBD (Crohn's disease, ulcerative colitis, celiac disease)

Study Design

Study Start date:
Estimated Completion Date:

Study Description

Connect with a study center

  • Paragon Rx Clinical, Inc.

    GARDEN GROVE, California 92840-3103
    United States

    Active - Recruiting

+−

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.